×
Back to Agenda
Live Oral Poster Presentations II
Learning Objective : NOTE: Abstract co-authored by lauren.pilling@roche.com & victor.gitman@roche.com To explore strategies that effectively anticipate and meet the developing safety needs of patients and healthcare professionals by delivering transparent and contextualised safety information at scale.
Speaker(s)
Lauren Pilling
Senior PV Process Director, F. Hoffmann-La Roche Ltd, Switzerland
Putting safety at the forefront of patient experiences
James Whitehead, MBA, MSC
Former Senior Director Device & Digital Safety - AstraZeneca, Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Digital Health: A boon or burden to PV? Analysis of the macroenvironment and forces challenging this opportunity
Christopher Golds
Safety Process Lead, GSK, United Kingdom
Clinical Utility Score for Prioritisation (CUSP), a Method to Identify High-Utility Safety Reports: A Prospective Assessment
Valentina Geisseler-Homann
Senior Clinical Trial Regulatory Lead, F. Hoffmann-La Roche Ltd, Switzerland
CTR Benefits and Challenges from the sponsor's perspective
Have an account?